Markets:

Overview

News

Currencies

International

Treasuries

Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

4.715 -0.205 (-4.17%)

Streaming Delayed Price Updated: 1:18 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rocket Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

June 06, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

June 02, 2025

From Pomerantz LLP

Via GlobeNewswire

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May ↗

May 31, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

These Analysts Slash Their Forecasts On Rocket Pharmaceuticals ↗

May 28, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

May 28, 2025

From Pomerantz LLP

Via GlobeNewswire

Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty ↗

May 28, 2025

Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.

Via Benzinga

Booz Allen, FreshPet, Rocket Pharma Downgraded, While Vail Resorts And FICO Get An Upgrade – Top Wall Street Analyst Calls Today ↗

May 28, 2025

State Street received an upgrade from Truist, raising the stock to ‘Buy’ from ‘Hold’ and increasing its price target to $112 from $85.

Via Stocktwits

Topics ETFs Stocks

Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

May 28, 2025

Via Benzinga

This Informatica Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday ↗

May 28, 2025

Via Benzinga

Patient Death In Rocket Pharma Trial Triggers Downgrades, But Retail Traders Bet Big On Strong Recovery ↗

May 28, 2025

Message volume on Stocktwits spiked to ‘extremely high’ levels, and the ticker added 20% more watchers.

Via Stocktwits

Topics Death

Here are the top movers in Tuesday's session. ↗

May 27, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 27, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

May 27, 2025

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Dow Surges Over 600 Points; US Durable Goods Orders Fall in April ↗

May 27, 2025

Via Benzinga

Topics Stocks

Rocket Pharma Reports Patient Death In Rare Disease Gene Therapy Trial, FDA Puts Clinical Hold ↗

May 27, 2025

Rocket Pharmaceuticals halted its Danon disease gene therapy trial after a patient death, with the FDA placing the study on clinical hold for review.

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

May 27, 2025

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings ↗

May 27, 2025

Via Benzinga

Rocket Pharmaceuticals Stock Drops Pre-Market After FDA Pauses Gene Therapy Trial Over Patient Death: Retail Turns Bullish ↗

May 27, 2025

Rocket Pharmaceuticals said that it is working with the FDA to ensure safety of all study patients and resume the trial “as expeditiously as possible."

Via Stocktwits

Stay updated with the stocks that are on the move in today's pre-market session. ↗

May 27, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 27, 2025

Via Benzinga

Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease

May 27, 2025

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says Analyst ↗

May 16, 2025

Chardan's Geulah Livshits raises target price for RCKT to $46 and maintains Buy rating after promising data on gene therapy for heart disease.

Via Benzinga

Pentair To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday ↗

May 16, 2025

Via Benzinga

Rocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of Gene and Cell Therapy

May 15, 2025

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy

May 09, 2025

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Rocket Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Progress

May 08, 2025

From Rocket Pharmaceuticals, Inc.

Via Business Wire

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday ↗

April 21, 2025

Via Benzinga

3 Stocks Insiders Are Buying Rapidly Amid Market Volatility ↗

April 17, 2025

Despite market volatility, these stocks are seeing strong buys by insiders.

Via Talk Markets

Topics Stocks / Equities

Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday ↗

April 15, 2025

Via Benzinga

Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

April 03, 2025

From Rocket Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.